{
    "2018-04-17": [
        [
            {
                "time": "",
                "original_text": "辉立证券：云南白药混改加速发展",
                "features": {
                    "keywords": [
                        "云南白药",
                        "混改",
                        "加速发展"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "国务院出台鼓励政策支持优质仿制药 4股总动员",
                "features": {
                    "keywords": [
                        "国务院",
                        "鼓励政策",
                        "优质仿制药"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "[看好评级] 医药生物行业2018年一季报业绩前瞻：稳健增长 分化明显 重点关注优质成长与稳健价值",
                "features": {
                    "keywords": [
                        "医药生物",
                        "2018年一季报",
                        "稳健增长",
                        "优质成长",
                        "稳健价值"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "云南白药:百年白药平稳增长,业绩有望重回快车道",
                "features": {
                    "keywords": [
                        "云南白药",
                        "平稳增长",
                        "业绩",
                        "快车道"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}